LifeStance director entities sell 5,101 LFST shares
LifeStance Health Group, Inc. director Robert Bessler reported open-market sales of company common stock on April 21, 2026 through entities he is associated with.
Rhea-AI Filing Summary
LifeStance Health Group, Inc. director Robert Bessler reported open-market sales of company common stock on April 21, 2026 through entities he is associated with. Shama LLC sold 2,550 shares and Vitthal LLC sold 2,551 shares at a weighted average price of $7.01 per share, within a range of $7.00 to $7.02.
After these sales, Shama LLC held 1,426,196 shares and Vitthal LLC held 1,309,397 shares of LifeStance common stock. Separate entries show 36,363 shares held indirectly, described as held by Alpine Glow Capital, and 57,619 shares held directly by Bessler. The reporting person disclaims beneficial ownership of the LLC- and Alpine Glow-held shares except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 2,551 | $7.01 | $18K |
| Sale | Common Stock | 2,550 | $7.01 | $18K |
| holding | Common Stock | -- | -- | -- |
| holding | Common Stock | -- | -- | -- |
Footnotes (4)
- F1. The price reported is a weighted average price. These shares were sold in multiple transactions ranging from $7.00 to $7.02 inclusive. The Reporting Person undertakes to provide to the Company, any security holder of the Company or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- F2. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act of 1934 (the "Exchange Act") or for any other purpose.
- F3. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
- F4. Shares held of record by Alpine Glow Capital. The Reporting Person is the manager and sole member of Alpine Glow Capital. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these securities on this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the reported securities for purposes of Section 16 of the Exchange Act or for any other purpose.
Key Figures
Key Terms
weighted average price financial
beneficial ownership financial
pecuniary interest financial
Section 16 regulatory
indirect ownership financial
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did LifeStance Health Group (LFST) report for Robert Bessler?
What is Alpine Glow Capital’s role in the LFST insider holdings disclosure?
AI-generated analysis. How Rhea-AI works. Not financial advice.